Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Would someone kindly explain this?

The Jan 2013 agreement was the settlement between Moore and TPL whereby PDS agreed to pay Moore a certain amount every month as a consulting fee. What I don't know is if Moore regained his ownership of the MMP or if that remains with TPL.

If the July 2012 (new ComAg) agreements become void pursuant to the document you referenced above, then wouldn't the agreements between PTSC and TPL revert back to the original ComAg which has a termination provision as follows:

6.2 P-Newco may terminate this Commercialization Agreement if:

c) TPL enters into a reorganization under Chapter 11 of the

United States Bankruptcy Code, and TPL ceases to be a debtor in possession

during the pendency of such bankruptcy proceeding.

Each of the events referred to in Sections 6.1 and 6.2 shall be

referred to as a "Termination Event". In no event shall the conduct of Moore be deemed to constitute a Termination Event.

http://www.sec.gov/Archives/edgar/data/836564/000114420405019003/v019805_ex10-41.txt

Please also note the following:

Pursuant to the Original ComAg 2005

3.6 Upon the termination of this Commercialization Agreement, Patriot shall be entitled to receive a copy of third party "DeCaps" (as such term is commonly understood to mean in the industry) related to the Commercialization and third party expert analyses thereof; and TPL does hereby consent to the deliveries thereof by such third party experts. In the event any of the

foregoing are not provided by such third parties, TPL will provide Patriot with copies of such documents in its possession. In addition, a Patriot

Representative shall be entitled to view such "DeCaps" on a quarterly basis, but shall not be entitled to make copies thereof. With the exception of TPL's obligations pursuant to Section 3.1 and this Section 3.6, TPL shall not be obligated to share any other materials related to the Commercialization, including without limitation any attorney work product generated during the term of this Commercialization Agreement or thereafter, which for all intents and purposes shall be deemed to be privileged, proprietary and exclusive to TPL.

Share
New Message
Please login to post a reply